Summary
Procaine esterase activity in plasma from patients with renal failure is decreased by 40%. Since cyanate is formed from urea and readily carbamylates certain blood proteins, a possible role for cyanate in the depression of plasma esterase activity in uraemic patients was considered. However, in vitro carbamylation of normal plasma in a range similar to that detected in uraemic patients did not influence procaine esterase activity. Kinetic analysis of the reaction showed that the maximal hydrolyzing capacity but not the Km in uraemic plasma was diminished (5.0±0.3×10−5 moles hydrolyzed per litre of plasma per minute and a Km of 3.9±0.2×10−5 mol/l in plasma from normal volunteers as compared to 3.1±0.1×10−5 mol/l/min and 3.5±0.2×10−5 ml/l in plasma from patients with renal failure). Therefore, not carbamylation but rather a decrease in enzyme synthesis is the likely explanation for the lower rate of procaine hydrolysis in uraemic plasma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Mc Ardle B (1940) The serum choline esterase in jaundice and disease of the liver. Q J Med 9: 107–127
Reidenberg MM, James S, Dring LG (1972) The rate of procaine hydrolysis in serum of normal and diseased patients. Clin Pharmacol Ther 13: 279–284
du Souich P, Erill S (1977) Metabolism of procainamide and p-aminobenzoic acid in patients with chronic liver disease. Clin Pharmacol Ther 22: 588–595
du Souich P, Erill S (1978) Metabolism of procainamide in patients with chronic heart failure, chronic respiratory failure and chronic renal failure. Eur J Clin Pharmacol 14: 21–27
Erill S, Calvo R, Carlos R (1980) Plasma protein carbamylation and decreased acidic drug protein binding in uremia. Clin Pharmacol Ther 27: 612–618
Bachmann K, Kalentovic M, Shapiro R (1980) A possible role for cyanate in the binding defect of uremia. Biochem Pharmacol 29: 1598–1601
Calvo R, Carlos R, Erill S (1982) Effects of carbamylation of plasma proteins and competitive displacers on drug binding in uremia. Pharmacology 24: 248–252
Hofstee BHJ (1952) Specificity of esterase. I. Identification of two pancreatic aliesterases. J Biol Chem 199: 357–364
Carreras, J, Chabas A, Diedrich D (1976) Physiological and clinical implications of proteins carbamylation. In: Grisolia S, Baguena R, Major F (eds) The urea cycle. Wiley, New York
Hunninghake D, Grisolia S (1966) A sensitive and convenient micromethod for estimation of urea, citrulline and carbamyl derivatives. Anal Biochem 16: 200–205
Dirnhuber P, Schutz F (1948) The isomeric transformation of urea into ammonium cyanate in aqueous solutions. Biochem J 42: 628–632
Fluckiger R, Harmon W, Meier W, Loo S, Gabbay KH (1981) Hemoglobin carbamylation in uremia. N Engl J Med 304: 823–827
Usubiaga JE, Wikingsky J, Ferrero R, Usubiaga LE, Wikinsky R (1966) Local anesthetic induced convulsions in man. Anesth Analg 45: 611–620
Green RL, Lewis JE, Kraus SJ, Frederickson EL (1974) Elevated plasma procaine concentrations after administration of procaine penicillin G. N Engl J Med 291: 223–226
Calvo R, Carlos R, Erill S (1979) Etomidate and plasma esterase activity in man and experimental animals. Pharmacology 18: 294–298
Calvo R, Carlos R, Erill S (1980) Effects of disease and acetazolamide on procaine hydrolysis by red blood cell enzymes. Clin Pharmacol Ther 27: 179–183
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Calvo, R., Carlos, R. & Erill, S. Procaine hydrolysis defect in uraemia does not appear to be due to carbamylation of plasma esterases. Eur J Clin Pharmacol 24, 533–535 (1983). https://doi.org/10.1007/BF00609899
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609899